Clinical Trial Update: Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of bortezomib, 5-fluorouracil, and external-beam radiation therapy in patients with stage II–IV rectal cancer; colorect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Velcade (bortezomib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED